OPTiNA Genesis

ARK INC.

South Korea

ARK INC. is a company dedicated to improving the quality of life for all people by developing early disease detection solutions based on artificial intelligence (AI). As a subsidiary of Pusan National University Hospital, ARK leverages trustworthy national university hospital data and a standardized clinical research system to develop highly accurate AI diagnostic algorithms. ⸻ Flagship Product – WISKY: AI-based Ophthalmic Disease Screening Solution WISKY, the flagship product of ARK, is an AI-powered retinal disease screening platform. Using a single fundus image, WISKY can simultaneously detect three major causes of blindness in real time: • Diabetic Retinopathy • Age-related Macular Degeneration (AMD) • Glaucoma Recognized for its diagnostic accuracy and ease of use, WISKY has been designated as an Innovative Medical Device in Korea. This technology is highly regarded for its market potential, especially amid the rising incidence of retinal diseases due to an aging population and chronic conditions. ⸻ Advanced AI Technology Powered by Big Data • ARK has built a comprehensive dataset of over 500,000 retinal images, which serves as the foundation for a robust and optimized AI training model. • The diagnostic system is user-friendly, allowing even non-specialist medical staff to operate it easily. • This makes it particularly suitable for primary care settings, such as community health centers and local clinics. With this technological advantage, ARK is actively expanding into global markets as well as strengthening its domestic presence.